Cargando…

MicroRNAs and Calcium Signaling in Heart Disease

In hearts, calcium (Ca(2+)) signaling is a crucial regulatory mechanism of muscle contraction and electrical signals that determine heart rhythm and control cell growth. Ca(2+) signals must be tightly controlled for a healthy heart, and the impairment of Ca(2+) handling proteins is a key hallmark of...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jae-Ho, Kho, Changwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508866/
https://www.ncbi.nlm.nih.gov/pubmed/34638924
http://dx.doi.org/10.3390/ijms221910582
_version_ 1784582199297703936
author Park, Jae-Ho
Kho, Changwon
author_facet Park, Jae-Ho
Kho, Changwon
author_sort Park, Jae-Ho
collection PubMed
description In hearts, calcium (Ca(2+)) signaling is a crucial regulatory mechanism of muscle contraction and electrical signals that determine heart rhythm and control cell growth. Ca(2+) signals must be tightly controlled for a healthy heart, and the impairment of Ca(2+) handling proteins is a key hallmark of heart disease. The discovery of microRNA (miRNAs) as a new class of gene regulators has greatly expanded our understanding of the controlling module of cardiac Ca(2+) cycling. Furthermore, many studies have explored the involvement of miRNAs in heart diseases. In this review, we aim to summarize cardiac Ca(2+) signaling and Ca(2+)-related miRNAs in pathological conditions, including cardiac hypertrophy, heart failure, myocardial infarction, and atrial fibrillation. We also discuss the therapeutic potential of Ca(2+)-related miRNAs as a new target for the treatment of heart diseases.
format Online
Article
Text
id pubmed-8508866
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85088662021-10-13 MicroRNAs and Calcium Signaling in Heart Disease Park, Jae-Ho Kho, Changwon Int J Mol Sci Review In hearts, calcium (Ca(2+)) signaling is a crucial regulatory mechanism of muscle contraction and electrical signals that determine heart rhythm and control cell growth. Ca(2+) signals must be tightly controlled for a healthy heart, and the impairment of Ca(2+) handling proteins is a key hallmark of heart disease. The discovery of microRNA (miRNAs) as a new class of gene regulators has greatly expanded our understanding of the controlling module of cardiac Ca(2+) cycling. Furthermore, many studies have explored the involvement of miRNAs in heart diseases. In this review, we aim to summarize cardiac Ca(2+) signaling and Ca(2+)-related miRNAs in pathological conditions, including cardiac hypertrophy, heart failure, myocardial infarction, and atrial fibrillation. We also discuss the therapeutic potential of Ca(2+)-related miRNAs as a new target for the treatment of heart diseases. MDPI 2021-09-30 /pmc/articles/PMC8508866/ /pubmed/34638924 http://dx.doi.org/10.3390/ijms221910582 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Park, Jae-Ho
Kho, Changwon
MicroRNAs and Calcium Signaling in Heart Disease
title MicroRNAs and Calcium Signaling in Heart Disease
title_full MicroRNAs and Calcium Signaling in Heart Disease
title_fullStr MicroRNAs and Calcium Signaling in Heart Disease
title_full_unstemmed MicroRNAs and Calcium Signaling in Heart Disease
title_short MicroRNAs and Calcium Signaling in Heart Disease
title_sort micrornas and calcium signaling in heart disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508866/
https://www.ncbi.nlm.nih.gov/pubmed/34638924
http://dx.doi.org/10.3390/ijms221910582
work_keys_str_mv AT parkjaeho micrornasandcalciumsignalinginheartdisease
AT khochangwon micrornasandcalciumsignalinginheartdisease